Dr. Baliga's 'Podkasts for Curious Docs'
π New Insights on Diverticulitis ππ¬π Did you know that while 1β4% of people with diverticulosis develop diverticulitis, it still accounts for ~200,000 hospitalizations annually in the US and >$6.3B in healthcare costs? ππ° β CT scan remains the gold standard for diagnosis πΌοΈ β Observation & pain control are first-line for uncomplicated cases π β Antibiotics reserved for high-risk groups (elderly, immunocompromised, pregnant, systemic illness) β οΈ β Surgery indicated for recurrent or complicated cases (fistula, stricture, perforation) βοΈ...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π¨ Hypertension remains the worldβs #1 killer β yet fewer than 1 in 4 patients achieve control. π Exciting innovations are reshaping the field: βοΈ Aprocitentan (endothelin receptor antagonist) β first new class in decades βοΈ siRNA (zilebesiran) β 6-monthly dosing, tackling adherence βοΈ Aldosterone synthase inhibitors β overcoming βaldosterone escapeβ βοΈ Non-steroidal MRAs & neprilysin inhibitors β precision targeting with broader benefits βοΈ Single-pill & quadpill combos β simplifying therapy, boosting adherence π Together,...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π Ramanuja (1017β1137 CE), one of Indiaβs greatest theologians, shaped Vishishtadvaita Vedanta (Qualified Non-Dualism). His vision of Atman (self) and Brahman (supreme reality), united through bhakti (devotion), transformed Hindu theology and inspired generations. ποΈπ π‘ His commentaries on the Upanishads, Bhagavad Gita, and Brahma Sutras laid the foundation of Sri Vaishnavism and emphasized a path of devotion, grace, and liberation (moksha). β¨ π A reminder for todayβs healthcare providers and leaders: true service blends knowledge, humility, and...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
𧬠South Asians make up 25% of the worldβyet just 3% of major cardiovascular trials. A new systematic review (310 RCTs, 1M+ participants) reveals stark underrepresentation, especially outside India. No South Asians in trials for heart failure, cardiac arrest, or valvular disease. π The data gap is realβand itβs limiting care. π We need global trial designs that are inclusive, disaggregated, and powered for equity. Letβs change the research playbook. π‘ #CardioTrials #SouthAsianHealth #DiversityInResearch #PrecisionMedicine #GlobalHealth ππ«π
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
πΆββοΈπ² New research alert! A massive natural experiment tracking 7,447 relocations across 1,609 US cities reveals that urban walkability directly boosts physical activity ποΈπͺ π Moving to more walkable cities increased daily steps by ~1,100 and doubled compliance with MVPA guidelines! π― A powerful case for urban design as preventive medicine. π A must-read for public health advocates, city planners, and digital health innovators! #Walkability #UrbanHealth #DigitalEpidemiology #MVPA #SmartCities #BuiltEnvironment #PublicHealth πββοΈπ
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π§ Salt sensitivity of blood pressure (SSBP) is an independent risk factor for CVD. πΉπΊ Women are more salt-sensitive than men, especially after menopause. βοΈ Key drivers: RAAS, ENaC, natriuresis, and immune pathways. π Estrogen protects, testosterone raises pressure, menopause tips the balance. π From Dahlβs rats to Connβs syndrome, SSBP research shows why sex-specific, personalized therapy is the future of hypertension care. π Nature Reviews Cardiology
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
Liver, Lipids, and the Left Ventricle π©Έπ«π§¬ The NEJM review reminds us that fatty liver isnβt just a liver problem. MASLD drives risk for heart disease, diabetes, kidney dysfunction, and even cancers. π¨ Cardiovascular disease remains the leading cause of death in MASLDβoutpacing cirrhosis and cancer. π«π With new tools like FIB-4, VCTE, ELF, and promising drugs such as resmetirom and GLP-1/GIP agonists, weβre entering an era where treating the liver can protect the heart. ππ± #MASLD #LiverHeartConnection #NEJM #CardiometabolicHealth
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π§π The COMBINE-AF substudy offers important guidance for managing frail, elderly, VKA-experienced patients with atrial fibrillation. Switching to standard-dose DOACs reduced stroke/systemic embolism risk and cut intracranial & fatal bleeding π§ π‘οΈ, but raised gastrointestinal bleeding rates π½οΈπ©Έβespecially with certain agents. Sensitivity analyses show apixaban & edoxaban may offer a safer bleeding profile. These findings highlight the need for shared decision-making βοΈ and integrated ABC pathway care β€οΈ to balance prevention, safety, and patient...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π§ Meet the Northwestern SuperAgersβindividuals 80+ with memory scores rivaling those decades younger! π They show thicker cortices, more von Economo neurons, fewer neurofibrillary tangles, and remarkable social engagement. π Their brains offer clues to resisting age-related declineβreshaping how we view aging potential. β¨ #SuperAgers #HealthyLongevity #BrainHealth
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
π¨ Hot off the press! The 2025 ACC/AHA High Blood Pressure Guidelines are here π©Ίπ β bringing sharper strategies to detect, treat & prevent hypertension. From HBPM π to PREVENT risk scoring π― and protecting against end-organ damage π«π§ , these updates empower clinicians & patients alike. Measure it. Manage it. Maintain it. πͺπ #Hypertension #Cardiology #Guidelines
info_outlineCOVID MATH for the Physician| Dr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians | Not Medical Advice or Opinion
Determining How Public Health Measures Might Be Slowing COVID-19 Using the Reproduction Number (Rt)